Package Leaflet: Information for the Patient
Urorec 8 mg Hard Capsules
Urorec 4 mg Hard Capsules
Silodosin
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
What is Urorec
Urorec belongs to a group of medicines called alpha-1A adrenergic receptor blockers.
Urorec is selective for receptors located in the prostate, bladder, and urethra. By blocking these receptors, it causes relaxation of the smooth muscle of these tissues. This makes it easier for you to urinate and alleviates your symptoms.
What Urorec is used for
Urorec is used in adult men to treat urinary symptoms associated with benign prostatic hyperplasia (BPH), such as:
Do not take Urorec
if you are allergic to silodosin or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Urorec
When taking Urorec, dizziness and, occasionally, fainting may occur when standing up, especially when starting treatment or if you are taking other medicines that lower blood pressure. If this happens, sit or lie down immediately until the symptoms disappear and inform your doctor as soon as possible (see also the section "Driving and using machines").
If your kidney problems are moderate, your doctor will start treatment with Urorec with caution and possibly with a lower dose (see section 3 "Dosage").
If your kidney problems are severe, you should not take Urorec.
Sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".
Children and adolescents
Do not give this medicine to children and adolescents under 18 years of age, as there are no relevant indications for this age group.
Taking Urorec with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Tell your doctor in particular if you are taking:
Pregnancy and breastfeeding
Urorec is not indicated for use in women.
Fertility
Urorec may reduce the amount of semen and temporarily affect your ability to conceive a child. If you intend to have a child, consult your doctor or pharmacist before using this medicine.
Driving and using machines
Do not drive or operate machinery if you feel faint, dizzy, or sleepy or have blurred vision.
Follow exactly the instructions for administration of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is one Urorec 8 mg capsule per day by oral administration.
Take the capsule always with food, preferably at the same time each day. Do not break or chew the capsule; swallow it whole, preferably with a glass of water.
Patients with kidney problems
If you have moderate kidney problems, your doctor may prescribe a different dose. For this purpose, the 4 mg Urorec hard capsule presentation is available.
If you take more Urorec than you should
If you have taken more than one capsule, inform your doctor as soon as possible. If you feel dizzy or weak, tell your doctor immediately.
If you forget to take Urorec
You can take the capsule later the same day if you forget to take it before. If it is almost time for the next dose, do not take the missed dose. Do not take a double dose to make up for the missed capsule.
If you stop taking Urorec
If you stop treatment, your symptoms may recur.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Get in touch with your doctor immediately if you experience any of the following allergic reactions, as their consequences could be serious: swelling of the face or throat, difficulty breathing, feeling of fainting, itching of the skin, or hives.
The most common side effect is a reduction in the amount of semen expelled during sexual intercourse. This effect disappears after stopping treatment with Urorec. Inform your doctor if you are planning to have children.
Dizziness, including dizziness when standing up, and, occasionally, fainting may occur.
If you feel weak or dizzy, sit or lie down immediately until the symptoms disappear. If you experience dizziness when standing up or fainting, inform your doctor as soon as possible.
Urorec may cause complications during cataract surgery (eye surgery for cataracts; see section "Warnings and precautions").
It is essential that you inform your ophthalmologist immediately if you are using or have previously used Urorec.
Other possible side effects are listed below:
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Frequency not known (frequency cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP". The expiry date is the last day of the month stated.
Do not store above 30°C.
Store in the original package to protect from light and moisture.
Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Urorec
Urorec 8 mg
The active substance is silodosin. Each capsule contains 8 mg of silodosin.
The other ingredients are pregelatinized corn starch, mannitol (E421), magnesium stearate, sodium lauryl sulfate, gelatin, titanium dioxide (E171).
Urorec 4 mg
The active substance is silodosin. Each capsule contains 4 mg of silodosin.
The other ingredients are pregelatinized corn starch, mannitol (E421), magnesium stearate, sodium lauryl sulfate, gelatin, titanium dioxide (E171), yellow iron oxide (E172).
Appearance of the product and pack contents
Urorec 8 mg are hard gelatin capsules, opaque, and white in color, size 0 (21.7 x 7.6 mm, approximately).
Urorec 4 mg are hard gelatin capsules, opaque, and yellow in color, size 3 (15.9 x 5.8 mm, approximately).
Urorec is available in packs of 5, 10, 20, 30, 50, 90, 100 capsules. Not all pack sizes may be marketed.
Marketing authorisation holder
Recordati Ireland Ltd.
Raheens East
Ringaskiddy Co. Cork
Ireland
Manufacturer
Recordati Industria Chimica e Farmaceutica S.p.A.
Via Matteo Civitali 1
20148 Milan
Italy
Laboratoires Bouchara-Recordati
Parc Mécatronic
03410 Saint Victor
France
You can obtain further information on this medicine by contacting the local representative of the marketing authorisation holder:
Belgium Recordati Ireland Ltd. Tel: + 353 21 4379400 | Lithuania Recordati Polska sp. z o.o. Tel: +48 22 206 84 50 |
Luxembourg Recordati Ireland Ltd. Tel: + 353 21 4379400 | |
Czech Republic Herbacos Recordati s.r.o. Tel: + 420 466 741 915 | Hungary Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Denmark Recordati Ireland Ltd. Tel: + 353 21 4379400 | Malta Focused Pharma Ltd. Tel: + 356 79426930 |
Germany Recordati Pharma GmbH Tel: + 49 731 70470 | Netherlands Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Estonia Recordati Polska sp. z o.o. Tel: +48 22 206 84 50 | Norway Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Greece Recordati Hellas Pharmaceuticals A.E. Tel: + 30 210-6773822 | Austria Recordati Austria GmbH Tel: + 43 676 353 0 262 |
Spain Casen Recordati, S.L. Tel: + 34 91 659 15 50 | Poland Recordati Polska sp. z o.o. Tel: + 48 22 206 84 50 |
France Laboratoires Bouchara-Recordati Tel: + 33 1 45 19 10 00 | Portugal Jaba Recordati, S.A. Tel: + 351 21 432 95 00 |
Croatia PharmaSwiss d.o.o. Tel: +385 1 63 11 833 | Romania Recordati România S.R.L. Tel: + 40 21 667 17 41 |
Ireland Recordati Ireland Ltd. Tel: + 353 21 4379400 | Slovenia Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Iceland Recordati Ireland Ltd. Tel: + 353 21 4379400 | Slovakia Herbacos Recordati s.r.o. Tel: + 420 466 741 915 |
Italy Recordati Industria Chimica e Farmaceutica S.p.A. Tel: + 39 02 487871 | Finland SwanMedica Oy Tel: +358 17 3690033 |
Cyprus G.C. Papaloisou Ltd. Tel: + 357 22 49 03 05 | Sweden Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Latvia Recordati Polska sp. z o.o. Tel: +48 22 206 84 50 | United Kingdom (Northern Ireland) Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Date of last revision of this leaflet 02/2025
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website: https://www.ema.europa.eu.
The average price of UROREC 8 mg HARD CAPSULES in October, 2025 is around 15.7 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.